Showing 41 - 60 of 369 results
Operation Art winner has passion for science
Year 11 STEM student and aspiring physicist was given the opportunity of a lifetime to tour ANSTO’s Lucas Heights campus and meet some of Australia’s top researchers.
Synchrotron saved with half billion dollar funding stream
Some of Sydney’s best science teachers meet its best science infrastructure
Nuclear medicine processing and distribution
ANSTO’s nuclear medicine processing and distribution facility assembles, loads, tests and distributes a range of nuclear medicine products, including Mo-99. The Mo-99 is dispensed into an ANSTO radiopharmaceutical Gentech® Generator where it decays to Tc-99m.
Leadership changes at ANSTO
This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.
Shutting down a nuclear reactor is a slow and methodical process: A closer look
The shutdown of a nuclear reactor can be done manually by an operator following a well-established operating procedure.
2023 Eureka Prize winners announced
Specialist expertise and capabilities at ANSTO enable an understanding and improvement of current and advanced nuclear fuel materials
With a well-established portfolio of nuclear research and the operation of Australia's only nuclear reactor OPAL, ANSTO scientists conduct both fundamental and applied research on fuel for current, advanced, and future nuclear technology systems.
Role at ANSTO
Cancer drug development to be turbocharged as ACRF funding brings ‘broadband’ protein analysis to Australia
Powerful mathematical calculations guide the startup of a nuclear reactor
The nuclear analysis team at ANSTO recently had a significant role in the re-design and optimisation of a cold neutron source facility for the reactor, its installation and the subsequent restart after a six-month shutdown.
Role at ANSTO
Internships provide valuable hands-on experience for young international researchers
ANSTO technology and expertise heading to Antarctica for atmosphere studies
Year in review
Top students selected to work with Australia's best Nuclear Scientists
This month ANSTO is opening its doors to 11 talented young people from across Australia as the two-year Graduate Program kickstarts.
Particle Accelerators
The Accelerator Science group purse a broad research program with the aims of improving the performance and reliability of our accelerators, increasing their research capabilities and developing the next generation of accelerator technology.
Advanced Diffraction & Scattering Beamlines (ADS-1 and ADS-2) UNDER CONSTRUCTION
The Advanced Diffraction and Scattering beamlines (ADS-1 and ADS-2) are two independently operating, experimentally flexible beamlines that will use high-energy X-ray diffraction and imaging to characterise the structures of new materials and minerals.
Safeguarding the future of Australia's nuclear medicine
The new facility will be built around a product line of ANSTO’s design – a new Technetium-99m generator – that will enable greater process automation than is possible with existing technology, leading to improvements in efficiency, quality and importantly the highest levels of production safety.